Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

Barrier Therapeutics, Inc. - Strategic Analysis Review

 

Publication Date March 2009
Publisher Global Markets Direct
Product Type Report
Pages 12
ISBN Number not applicable
Product Code GMD01877

Price

£83.00
approximately: $126 | €93

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Barrier Therapeutics, Inc. - Strategic Analysis Review

Barrier Therapeutics (Barrier) is a pharmaceutical company engaged in the research, development and commercialization of pharmaceutical products related to the dermatology. The company is headquartered at Princeton in New Jersey, United States and has operations in the U.S., Canada and Belgium. Barrier operates in only one reportable segment namely Dermatology.

Global Markets Direct, the leading business information provider, presents an in-depth strategic and operational analysis of Barrier Therapeutics, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.

Scope

  • The company's strengths and weaknesses and areas of development or decline are analyzed. Strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitors' weaknesses and target the market opportunities available to them.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic and operational performance.

This report covers the following industry codes:

SIC Code: 8731

NAICS Code: 54171

Contents

  • Key Information
  • Key Facts
  • List of Tables
    • Company Overview
    • Major Products and Services
    • Overview
    • History
    • SWOT Analysis Overview
    • Overview
    • Barrier Therapeutics, Inc. - Strengths
    • Agreements
    • Unique Products
    • Barrier Therapeutics, Inc. - Weaknesses
    • Limited Customers
    • Dependence on Contract Manufacturers
    • Barrier Therapeutics, Inc. - Opportunities
    • Product Approvals
    • Product Launch
    • Emerging Markets
    • Rising Healthcare Expenditure in the US
    • Barrier Therapeutics, Inc. - Threats
    • Patent Expiration
    • Tightening of the FDA's Regulatory Oversight
    • Impact of the Financial Crisis
    • Emergence of Biogenerics / Biosimilars
    • Industry Consolidation
    • Key Competitors
    • Key Employees
    • Key Employee Biographies
    • Company Statement
    • Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
    • Appendix
    • Methodology
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • Barrier Therapeutics, Inc., Key Facts
    • Barrier Therapeutics, Inc., Key Employees
    • Barrier Therapeutics, Inc., Key Facts
    • Major Products and Services
    • Barrier Therapeutics, Inc., History
    • Barrier Therapeutics, Inc., Key Employees
    • Barrier Therapeutics, Inc., Key Employee Biographies
    • Barrier Therapeutics, Inc., Subsidiaries
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Primary Research Data